CNTX - Context Therapeutics GAAP EPS of -$0.93 March, 22 2023 05:22 PM Context Therapeutics Inc. 2023-03-22 17:22:56 ET Context Therapeutics press release ( NASDAQ: CNTX ): FY GAAP EPS of -$0.93. Cash, cash equivalents, and restricted cash were $35.5 million at December 31, 2022, compared to $49.7 million at December 31, 2021. For further details see: Context Therapeutics GAAP EPS of -$0.93